Oramed Insulin Capsule: Additional Phase IIa data

Additional data from a single-blind, open-label, Israeli Phase IIa trial in 8 Type I diabetics showed that oral ORMD-0801 administered 10, 45 or 90 minutes prior to a standard meal significantly incre...